Halank M - Search Results

1

Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension.

Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M, Meyer FJ, Karger G, Buss J, Juenger J, Holzapfel N, Opitz C, Winkler J, Herth FF, Wilkens H, Katus HA, Olschewski H, Grünig E. Mereles D, et al. Among authors: halank m. Circulation. 2006 Oct 3;114(14):1482-9. doi: 10.1161/CIRCULATIONAHA.106.618397. Epub 2006 Sep 18. Circulation. 2006. PMID: 16982941 Clinical Trial.

2

[Sildenafil in pulmonary hypertension].

Ewert R, Höper M, Halank M, Winkler J, Wensel R, Opitz C. Ewert R, et al. Among authors: halank m. Pneumologie. 2003 May;57(5):291; author reply 291-2; discussion 292. Pneumologie. 2003. PMID: 12825577 German. No abstract available.

3

Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension.

Koehler R, Grünig E, Pauciulo MW, Hoeper MM, Olschewski H, Wilkens H, Halank M, Winkler J, Ewert R, Bremer H, Kreuscher S, Janssen B, Nichols WC. Koehler R, et al. Among authors: halank m. J Med Genet. 2004 Dec;41(12):e127. doi: 10.1136/jmg.2004.023101. J Med Genet. 2004. PMID: 15591269 Free PMC article. No abstract available.

4

Bosentan therapy for portopulmonary hypertension.

Hoeper MM, Halank M, Marx C, Hoeffken G, Seyfarth HJ, Schauer J, Niedermeyer J, Winkler J. Hoeper MM, et al. Among authors: halank m. Eur Respir J. 2005 Mar;25(3):502-8. doi: 10.1183/09031936.05.00080804. Eur Respir J. 2005. PMID: 15738295 Free article.

5

Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension.

Opitz CF, Wensel R, Winkler J, Halank M, Bruch L, Kleber FX, Höffken G, Anker SD, Negassa A, Felix SB, Hetzer R, Ewert R. Opitz CF, et al. Among authors: halank m. Eur Heart J. 2005 Sep;26(18):1895-902. doi: 10.1093/eurheartj/ehi283. Epub 2005 May 11. Eur Heart J. 2005. PMID: 15888496

6

[Assessment of cardiopulmonary function at rest and during exercise in patients with pulmonary hypertension].

Ewert R, Opitz CF, Wensel R, Halank M, Winkler J, Lodziewski S, Felix SB. Ewert R, et al. Among authors: halank m. Herz. 2005 Jun;30(4):318-25. doi: 10.1007/s00059-005-2690-9. Herz. 2005. PMID: 15965809 Review. German.

7

[A role for combination therapy in pulmonary arterial hypertension].

Behr J, Borst MM, Winkler J, Hoeper M, Halank M, Ghofrani A, Klose H, Wilkens H, Stähler G. Behr J, et al. Among authors: halank m. Pneumologie. 2005 Oct;59(10):730-5. doi: 10.1055/s-2005-915556. Pneumologie. 2005. PMID: 16222588 German.

8

Successful switch from long-term intravenous iloprost to non-invasive combination therapy in idiopathic pulmonary arterial hypertension.

Halank M, Kolditz M, Opitz C, Hoeffken G, Ewert R. Halank M, et al. Wien Klin Wochenschr. 2006 Feb;118(1-2):54-9. doi: 10.1007/s00508-005-0507-8. Wien Klin Wochenschr. 2006. PMID: 16489527

9

[Severe refractory pulmonary hypertension after liver transplantation for hepatitis C liver cirrhosis].

Halank M, Ewert R, Opitz C, Seyfarth HJ, Höffken G. Halank M, et al. Z Gastroenterol. 2006 Apr;44(4):346-7; author reply 348. Z Gastroenterol. 2006. PMID: 16708443 German. No abstract available.

10

Combining inhaled iloprost with bosentan in patients with idiopathic pulmonary arterial hypertension.

Hoeper MM, Leuchte H, Halank M, Wilkens H, Meyer FJ, Seyfarth HJ, Wensel R, Ripken F, Bremer H, Kluge S, Hoeffken G, Behr J. Hoeper MM, et al. Among authors: halank m. Eur Respir J. 2006 Oct;28(4):691-4. doi: 10.1183/09031936.06.00057906. Eur Respir J. 2006. PMID: 17012628 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters